CRISPR in the Clinic
Type
Blog Post
Published
Nov. 2, 2023, 1:15 p.m.
...clinical trial for SCD in 2022 and Editas Medicine starting a Cas12-based clinical trial for SCD in 2022 as well... promising CRISPR targets — Sickle Cell Disease (SCD) and Transfusion-dependent beta thalassemia (TBT)...